Cargando…
cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance
In the last decade, the tyrosine kinase receptor cMET, together with its ligand hepatocyte growth factor (HGF), has become a target in non-small cell lung cancer (NSCLC). Signalization via cMET stimulates several oncological processes amongst which are cell motility, invasion and metastasis. It also...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491670/ https://www.ncbi.nlm.nih.gov/pubmed/25815459 http://dx.doi.org/10.3390/cancers7020556 |